GRE
INVESTMENT ADVISORS LIMITED
We are a SFC licensed corporation in Hong Kong which provides Investment Advisory and Asset Management services
GRE
INVESTMENT ADVISORS LIMITED
GRE投资咨询有限公司(“GRE”)是一家由香港证券及期货事务监察委员会(“SFC”)批准许可,
提供投资咨询和资产管理服务的公司。
ABOUT US
GRE
INVESTMENT ADVISORS LIMITED
GRE Investment Advisors Limited (“GRE”) is licensed by the Hong Kong Securities & Futures Commission (“SFC”) to provide investment advisory and asset management services, under type 4 (Advising on Securities) and Type 9 (Asset Management) licenses. Mr. Kevin Yip, Mr. Kester Ng, Mr. Jimmy Woo and Mr. Cary Zhou, the professional team has achieved outstanding equity investment return in the Greater China and Asia Pacific Region.
关于我们
GRE
INVESTMENT ADVISORS LIMITED
GRE投资咨询有限公司(“GRE”)是一家由香港证券及期货事务监察委员会(“SFC”)批准许可,提供投资咨询和资产管理服务的公司。GRE拥有第四类(证券咨询)及第九类(资产管理)牌照。在公司管理人叶家祺先生、吴绳祖先生、吴积民先生以及周永凯先生的带领下,专业团队在大中华区及亚太区都取得了杰出的股权投资回报。
PORTFOLIO
  • Genor Biopharma
    Genor Biopharma Company Limited (“Genor”) is a leading biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. Based in Shanghai, the Company was a spin-off from Walvax Biotechnology Company in June 2018 that was led by Hillhouse Capital and Hangzhou Tigermed Consulting.  Genor has successfully developed drug candidates targeting pathways with blockbuster potentials, encompassing top three oncology targets and five out of the ten bestselling drugs globally. Genor has established a pipeline of 15 targeted drug candidates with strong commercialization potentials in China that cover both proven and novel biological pathways. Genor currently has around 400 employees across 3 locations in China (Shanghai, Yunnan Yuxi and Beijing) as well as a lab in San Francisco, USA.
    For more details,
  • Ping An Good Doctor (PAGD)
    PAGD was founded by the Ping An Group in August 2014. The Company is a pioneer in the PRC Internet healthcare market and operate the largest Internet healthcare platform in terms of average MAUs and daily average online consultations. Through its mobile platform launched in April 2015, PAGD offers online medical and wellness services, such as family doctor services, consumer healthcare services, health mall as well as health management and wellness interaction. PAGD was listed in the Hong Kong Stock Exchange on May 4, 2018 (HKSE stock code: 1833).
    For more details,
    please refer to https://www.jk.cn/aboutUs
  • LUFAX
    Founded by the Ping An Group in Sep 2011, Lufax is a Leading Online Wealth Management platform in China. The Company’s business includes three major platforms: wealth management business, credit management business, and institutional service business.
    For more details,
  • VCredit
    Founded in 2006, VCredit is one of the pioneers of unsecured consumer credit in China. The Company has since grown into a leading on-line consumer credit company providing its users with a fully online credit services platform. VCredit was listed on the Hong Kong Stock Exchange on June 21, 2018 (HKSE stock code: 2003).
    For more details,
  • Tuhu.cn
    The Company was founded in Shanghai in 2011 and is now the largest auto care e-commerce platform in China, providing customers with a comprehensive B2C auto-care services platform.
    For more details,
  • Mafengwo
    Founded in 2011, the Company is a leading online travel platform in China, providing users with trip planning advise and online booking service during their travel by a variety of user-generated contents and online merchants.
    For more details,
    please refer to http://www.mafengwo.cn/
投资案例
  • 嘉和生物药业
    嘉和生物药业有限公司(“嘉和”)是一家领先的生物制药公司,专注于肿瘤及自身免疫药物的研发和商业化。公司总部位于上海,由高瓴资本和杭州泰格医药科技股份有限公司主导,于2018年6月从云南沃森生物技术股份有限公司分拆成立。嘉和已成功研发出靶向通路且极具潜力的候选药物,涵盖全球前三大肿瘤靶标及十款畅销药物中的五款。嘉和已建立由15款靶向候选药物组成的产品管线,该等药物在中国具有巨大的商业潜力,涵盖已知及新型生物学通路。嘉和已在中国设立了三大办事处(上海、云南玉溪和北京),并在美国旧金山创立了实验室。公司目前拥有约400名员工。
    更多详情,请参阅  https://www.genorbio.com/cn/about-genor/
  • 平安好医生
    平安好医生由平安集团于2014年8月成立。平安好医生是中国互联网医疗市场的先行者,运营着中国最大的互联网医疗平台(根据平均月活和每日平均在线问诊量衡量)。 通过2015年4月推出的移动平台,平安好医生提供在线医疗和健康服务,例如家庭医生服务、用户健康服务、健康商城以及与用户的健康管理互动。 平安好医生已于2018年5月4日在香港证券交易所上市(股票代码:1833)。
    更多详情,请参阅  https://www.jk.cn/aboutUs
  • 陆金所
    平安集团于2011年9月成立陆金所,陆金所是一家中国领先的在线财富管理平台。公司主营业务包括:财富管理业务、信用管理业务、机构服务业务。
    更多详情,请参阅  https://www.lu.com/about/aboutus.html
  • 维信金科
    维信金科成立于2006年,是中国消费信贷的探索者。该公司已经成长为一家领先的在线消费金融公司,为其用户提供全面的在线信贷服务。 维信金科已于2018年6月21日在香港证券交易所上市(股票代码:2003)。
    更多详情,请参阅  https://www.vcredit.com/about-us/about-us/
  • 途虎养车
    途虎养车于2011年成立于上海,目前是中国最大的汽车养护电商平台,为用户提供全面的B2C汽车养护服务。
  • 马蜂窝
    马蜂窝成立于2011年,是中国领先的在线旅游社区之一。马蜂窝通过用户原创内容和其线上电商服务,为用户提供旅游规划建议和在线预订。
    更多详情,请参阅  http://www.mafengwo.cn/
SERVICES

We provides investment advisory and asset management services to instititutions and high net worth individuals and families. Our focus includes private equity funds, direct investments and hedge funds.

We are an advisor to NM Strategic Management, LLC, the investment manager of NM Strategic Focus Fund. NM Strategic Focus Fund is a private equity fund with a focus on making direct investments in companies in the areas of technology, fintech, health care and consumer services in the People’s Republic of China.

服务

我们为机构及高净值客户提供投资咨询和资产管理服务。我们致力于私募股权基金、直接投资和对冲基金领域的投资服务。

我们是NM Strategic Management, LLC的咨询顾问,而NM Strategic Management, LLC为NM Strategic Focus Fund的基金管理人。NM Strategic Focus Fund是一家私募股权基金,专注于投资中国境内的高科技、金融科技、医疗健康以及消费服务行业的直接投资。

MANAGEMENT TEAM
  • Mr. Ng joined GRE as the CEO and NewMargin as a Managing Partner in June 2013. Mr. Ng has over twenty-one years of Global Investment Banking experience spanning across Hong Kong, China, the Asia Pacific region, New York, Sydney and London.

    Before joining GRE and NewMargin, Mr. Ng worked at J.P. Morgan for 7 years and he was Chairman as well as head of J.P. Morgan’s Asia Pacific Equity Capital and Derivatives Markets, focus on raising capital for both public and private companies via Initial Public Offerings, Equity & Equity-linked Offerings as well as pre-IPO private Placements.Prior to joining J.P. Morgan in 2006, Mr. Ng was at Merrill Lynch for over ten years and was a Managing Director and Head of Great China Equity Capital Markets. Prior to that, he has also worked at UBS’ Advisory & Financing Division in London and Goldman Sachs, Equity Capital Markets Division in London and Hong Kong.

    Throughout his Career, he has worked on some 500 equity and equity-linked transactions in Asian Pacific, including some 250 transactions for Greater China Companies, raising some $180 billion for them. In addition, he has worked on over 90 initial public offerings and pre-IPO placements, raising over $100 billion for Greater China companies listed on most of the major stock exchanges globally (Hong Kong, New York, London, Singapore, NASDAQ, etc.).

    Besides his Equity Capital Markets roles at J.P. Morgan, he has served as a director of the boards of both J.P Morgan Securities (Asia Pacific) Limited and J.P. Morgan Broking (Hong Kong) Limited. He was also a member of the J.P. Morgan Asia Pacific Equity Commitment Committee which is responsible for vetting and approving all of J.P. Morgan’s equity & equity linked transactions across the Asia Pacific Region. In addition, he also previously served as a Hong Kong SFC Responsible Officer as well as a Hong Kong Monetary Authority Executive Officer.

  • Mr. Yip is the managing director and responsible officer of GRE Investment Advisors Limited. He has more than twenty-five years of investment experience in private equity, alternative and portfolio investment in Greater China and the Asia Pacific region.

    Mr. Yip was previously the Vice Chairman (International) of New Margin Ventures, a leading mid-market growth private equity firm focused on investing in Greater China. Before joining New Margin, he was the Managing Director and Responsible Officer of Bosera Asset Management (International) Co., Ltd. Prior to Bosera, he was the co-founder and CEO of Sun Partners Investment Management Limited, a HK SFC-licensed asset management company which managed the Sun China Fund. Prior to that, he was a founding Senior Partner of GEMS and was a member of the firm’s investment committee. He was also a Vice President of J.P. Morgan International Capital Corporation from 1989 to 1998.

    Mr. Yip is an independent non-executive director of Shun Tak Holdings Limited (SEHK Stock Code: 242), a company listed on the Main Board of the Stock Exchange. Mr. Yip is also a non-executive director and a member of the audit committee of VCREDIT Holdings Limited (SEHK Stock Code: 2003).

    Mr. Yip is currently a member of the Investment Advisory Committee of EQT Partners, a leading private equity group in Europe, which works with portfolio companies to achieve sustainable growth, operational excellence and market leadership.

    Mr. Yip holds an A.B. Degree in Economics (magna cum laude) from Harvard University and was a John Harvard scholar. He sits as a non-scientific member of the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster and is also a member of the board of trustees of Milton Academy, Massachusetts, USA. He was chairman emeritus of the Hong Kong Venture Capital and Private Equity Association. Mr. Yip had also served on the Financial Services Advisory Committee of the Trade Development Council of the Hong Kong Special Administrative Region of the People’s Republic of China.

  • Richard Taylor joined GRE as a Managing Director in September 2020 following a more than 25 year career in global investment banking, for the majority of which he was based in Hong Kong and working in a pan Asian role in both emerging and frontier markets in the region.

    For the past 20 years Mr Taylor established, developed and managed the Asian regional investment banking business of CLSA as the Head of Corporate Finance and Capital Markets, managing a team in 11 Asian regional offices advising and raising capital for companies and institutions in the private and public capital markets.

    In addition to Hong Kong and Greater China, key markets of focus have been Indonesia, Philippines, Malaysia, Singapore, Thailand and India with a special emphasis on the healthcare, technology, gaming and consumer sectors.

    Mr. Taylor completed more than 200 regional transactions raising in excess of US$200b on behalf of clients, serving as a Board Director of CLSA Capital Markets Limited, as well as a member of the Executive, Risk and Underwriting Committees.

    Richard holds an MA in Modern History from Oxford University and is an Associate Member of the Chartered Institute of Management Accountants.

  • Mr. Woo is the Managing Director and Responsible Officer of GRE. Mr. Woo has 30 years of experience in the finance industry, specializing in the corporate finance and asset management.

    He was with JP Morgan for 15 years, holding various investment banking and asset management positions in Hong Kong and New York. He also held investment banking position with DBS Bank, as Managing Director and Head of DBS Asian Capital Ltd.

    Mr. Woo also had experience as a regulator for 3 years in Hong Kong, serving as an executive director of the Mandatory Provident Fund Schemes Authority. Mr. Woo is a Chartered Financial Analyst, and obtained a B.Sc degree from University of Calgary and an MBA from the University of Hong Kong.

  • Mr. Cary Zhou is a partner of GRE and previously served as a Senior Partner with New Margin Ventures since 2007.

    For over the years, Mr. Zhou has worked throughout China beginning with AT&T Bell Labs as senior engineer for telecommunications, followed by a move to Lucent Technology (China) resulting in his role as a Vice President of Sales & Marketing. At Lucent, he was the Chief Representative of Lucent Technology for southern China, where he was responsible for the oversight of all of Lucent's activities in the region, including with respect to government relationships. Mr. Zhou also set up the Lucent Joint Venture in China and was the General Manager for Lucent Technologies of Shanghai Joint Venture.

    Mr. Zhou received his B.S. and M.S. degrees in Electrical Engineering from the Polytechnic University of New York. He has industry background, extensive government relationships in China, experience with publicly traded companies and demonstrated business expertise.

  • Mr. Zhuo is a venture partner of GRE and a founding partner of V-star Capital. Before V-star, Mr. Zhuo served as a partner in New Margin Ventures from 2009 to 2017. Prior to New Margin, he worked for J.P Morgan Securities (Asia Pacific) Limited for 5 years, participating in a series of global IPOs and M&A for Chinese companies.

    Mr. Zhuo received his bachelor’s degree in International Securities, Investment and Banking (ISIB) from ICMA Centre, the University of Reading.

  • Mr. Xu is the Vice President of GRE and NM Strategic Focus Fund L.P. He joined NM Strategic Partners, which is an independent USD GP sponsored by the NewMargin Group, since 2015. Before NewMargin, He was working as an auditor in Deloitte from 2010, mainly serving companies listed in US or compliance with US GAAP.

    Mr. Xu received his bachelor’s degree of Economics from the Shanghai University of Finance and Economics (2006-2010), as well as a diploma of Finance and Economics from the University of Southampton (2008-2009). Mr. Xu mainly focuses on TMT related sectors and AI at growth stage in China. Mr. Xu has earned the Chartered Financial Analyst (CFA) designation.

  • Mrs. Gong serves as an associate of GRE. Prior to joining GRE, Mrs. Gong has 6-year working experience in the private equity sector, focusing on post-investment management and fund operation.

    Mrs. Gong was previously an auditor at PWC, focusing on the private equity and mutual fund sector. During that period, she provided assurance service, including statutory audit and internal control services, to over 30 funds across China.

    Mrs. Gong received her bachelor’s degree of Economics from Shanghai University of Finance and Economics in 2011.

  • Mrs.Zhao is an associate of GRE.

    Before GRE, she was an analyst at East Bell Venture Capital, one of the leading venture capitals in China, focusing on B2B related sectors. Before East Bell, she works for the Meritco Group, one of the leading management consulting companies in China founded by McKinsey senior alumnus, specializing in providing commercial due diligence for top venture capitals and private equities globally, as well as corporation strategy management for top internet enterprises in China.

    Mrs.Zhao received her bachelor’s degree of Management from Shanghai University of Finance and Economics in 2013, and a master’s degree of International Business from Monash University in Australia in 2015 with a distinction performance.

  • Mr. Choi is the Chief Financial and Compliance Officer of GRE. Mr. Choi has 20 years of working exposure in the finance industry and has accumulated extensive experiences in financial control, compliance and risk management.

    Mr. Choi was the finance head for more than 10 years in GEMS, which is a private equity management company with over US$800 million under management for investing in private equity situations in China and Asian. During that period, Mr. Choi also served to manage the accounting and finance activities for the family office of Mr. Simon Murray. Prior to joining GEMS in 2000 Mr. Choi worked in a listed company for 6 years, focusing on financial control, corporate finance and asset management.

    Mr. Choi obtained a bachelor’s degree in business administration (second honor), a postgraduate diploma in Accounting (distinction), and a master’s degree in Christian Studies.

管理团队
  • 吴绳祖先生于2013年6月加入GRE,担任首席执行官,并在上海永宣创业投资管理有限公司(NewMargin Ventures)担任管理合伙人。吴先生拥有超过21年的全球投资银行经验,遍及香港、中国内地、亚太地区、纽约、悉尼和伦敦。

    在加入GRE和上海永宣之前,吴先生在摩根大通工作了7年,是摩根大通亚太股权和衍生品市场部门(Equity Capital and Derivatives Markets)的主席以及部门主管,专注于通过首次公开发行(IPO)等方式为上市和私营企业融资。 在2006年加入摩根大通之前,吴先生在美林证券(现美银美林)有十余年工作经验,并曾任美林大中华区股权资本市场(Great China Equity Capital Markets)董事总经理和主管。此前,他还在瑞银伦敦的咨询与融资部门(Advisory & Financing Division),以及高盛伦敦和香港的股权资本市场部门(Equity Capital Markets Division)工作。

    吴绳祖先生参与了亚太地区约500笔股权和股权相关交易,包括了为大中华区企业服务的约250笔交易,为这些公司筹集了约1,800亿美元的资金。此外,他还参与了90多宗IPO和Pre-IPO的交易,为在全球大多数主要证券交易所(香港、纽约、伦敦、新加坡、纳斯达克等)上市的大中华区公司筹集了逾1000亿美元资金。

    除了在摩根大通担任股权资本市场的职务外,他还曾同时担任摩根证券(J.P Morgan Securities)亚太区及摩根大通期货(J.P. Morgan Broking)香港董事会的董事。另外,他也是摩根大通亚太区股权承诺委员会(Equity Commitment Committee)的成员,该委员会负责审批摩根大通在亚太区的所有股权和股权相关交易。此外,他亦曾担任香港证监会的负责官员及香港金融管理局执行官。

  • 叶先生是GRE投资咨询有限公司的常务董事兼负责人。他拥有大中华区及亚太地区超过25年的私募股权、另类投资和证券投资经验。

    叶先生曾担任上海永宣创业投资管理(国际)有限公司(NewMargin Ventures)的副董事长。上海永宣是一家中国领先的成长期风险投资公司。加入上海永宣之前,他是博时资产管理(国际)有限公司(Bosera Asset Management)的董事总经理兼负责人。加入博时之前,他是恒昇投资管理有限公司(Sun Partners Investment)的联合创始人兼首席执行官。恒昇投資管理有限公司是香港证监会授权的资产管理公司,管理着恒昇中国基金(Sun China Fund)。加入恒昇之前,他曾是General Enterprise Management Services (GEMS)的创始人之一,也是公司投资委员会的成员。1989至1998年,他曾担任摩根大通国际资本公司(J.P. Morgan International Capital Corporation)的副总裁。

    叶先生是港交所主板上市的信德集团有限公司(股票代码:242)的独立非执行董事。他也是维信金科控股有限公司的非执行董事及审计委员会成员(股票代码:2003)。

    叶先生现为殷拓集团(EQT Partners)投资咨询委员会的成员。殷拓集团是一家欧洲领先的私募股权投资集团,致力于通过与其被投企业的联动,提高其被投企业可持续增长能力、运营效率及市场地位。

    叶先生在哈佛大学以优异的成绩(magna cum laude)获得经济学学士学位,并且获得John Harvard奖学金(前5%)。他现为香港大学/医院管理局-港岛西医院联网(University of Hong Kong/Hospital Authority Hong Kong West Cluster)的机构审查委员会非科学成员,以及美国麻萨诸塞州弥尔顿学院(Milton Academy, Massachusetts, USA)的校董会成员。他曾任香港创业及私募投资协会的名誉主席,也曾担任中华人民共和国香港特别行政区贸易发展局金融服务咨询委员会委员。

  • 泰莱先生于2020年9月加入GRE并担任董事总经理。泰莱先生此前在国际投资银行工作了25年,并在香港负责亚太地区新兴市场的投融资工作。

    过去20年,泰莱先生担任中信里昂证券(CLSA)亚太区企业融资及资本市场主管,负责建立、开发和管理CLSA亚太地区的投资银行业务。他带领团队管理着CLSA的11个亚洲区办事处,为上市、非上市企业以及机构提供咨询和融资服务。

    除香港和大中华地区外,泰莱先生重点关注的市场还包括印度尼西亚、菲律宾、马来西亚、新加坡、泰国和印度,并专注于医疗、科技、游戏和消费领域。

    泰莱先生此前在中信里昂证券资本市场有限公司(CLSA Capital Markets Limited)担任董事,同时担任执行、风险和承销委员会(the Executive, Risk and Underwriting Committees)委员,并帮助客户进行了200多次交易、筹集资金超过2000亿美元。

    泰莱先生拥有牛津大学近代史硕士学位,并且是英国特许管理会计师公会(CIMA)的会员。

  • 吴积民先生是GRE的常务董事兼负责人。吴先生在金融行业有30年的从业经验,专注于企业理财和资产管理。

    吴先生在摩根大通工作了15年,曾在香港和纽约担任众多投资银行和资产管理的职位。他还曾在星展银行担任其亚洲资本有限公司董事总经理及主管。

    吴先生亦曾在香港监管机构从业3年,担任强制性公积金计划管理局(Mandatory Provident Fund Schemes Authority)的执行董事。 吴先生是一名特许金融分析师,并获得加拿大卡尔加里大学理学学士学位及香港大学工商管理硕士学位。

  • 周永凯先生是GRE的合伙人。

    自2007年以来,他也曾担任上海永宣创业投资管理有限公司(NewMargin Ventures)的高级合伙人。多年来,周先生一直在中国各地工作。周先生的职业生涯从在美国电话电报公司贝尔实验室(AT&T Bell Labs)担任电信高级工程师开始,后来进入朗讯科技(中国)担任销售和营销副总裁。

    他是朗讯技术中国华南地区的首席代表,负责监督朗讯在该地区的所有活动,其中包括与政府关系的处理。周先生还在中国设立合资企业,并担任朗讯上海合资企业的总经理。

    周先生持有纽约理工大学电气工程学学士和硕士学位。他在中国有广泛的行业背景和政府关系,以及与各类上市公司的合作经验。

  • 卓星煜先生是GRE的风险合伙人及源星资本的创始合伙人。

    在创立源星资本之前,卓先生曾于2009至2017年担任上海永宣创业投资管理有限公司(NewMargin Ventures)的合伙人。在上海永宣之前,他在摩根证券(亚太)有限公司工作5年,参与过一系列中国企业在全球IPO和并购活动。

    卓先生于英国雷丁大学国际金融市场管理中心获得国际证券、投资及银行学学士学位(ISIB)。

  • 许晓辰先生是GRE的副总裁。自2015年起,他加入了上海永宣创业投资管理有限公司(NewMargin Ventures)的独立的美元基金团队。在上海永宣之前,他自2010年起在德勤担任审计师,主要服务于在美国上市或符合美国公认会计准则的中国企业。

    许先生获得上海财经大学经济学学士学位(2006-2010),及英国南安普顿大学金融经济学学位证书(2008-2009)。许先生主要专注于中国互联网相关行业以及人工智能方向的投资及研究。许先生是一名注册金融分析师(CFA)。

  • 龚晓蓉女士是GRE的投资经理。在加入GRE之前,龚女士在私募股权领域有6年的工作经验,专注于投后管理和基金运营。

    龚女士曾在普华永道担任审计师,专注于私募股权和共同基金领域。在此期间,她为全国30多家私募和公募基金提供保证服务,包括法定审计和内部控制。

    龚女士于2011年获得上海财经大学经济学学士学位。

  • 赵越女士是GRE的投资经理。

    在加入GRE之前,她是钟鼎创投的分析师,专注于B2B相关领域。在此之前,她服务于久谦咨询,专门为全球顶级风险投资和私募股权机构提供商业尽职调查,以及为中国顶级互联网企业提供企业战略管理。

    赵女士于2013年获得上海财经大学管理学学士学位,2015年以优异成绩获得澳大利亚莫纳什大学国际商务硕士学位。

  • 蔡啟舜先生是GRE的首席财务和合规官。蔡先生在金融行业拥有20多年的工作经验,并在内部控制、合规和风险管理方面积累了丰富的经验。

    蔡先生曾在General Enterprise Management Services (GEMS)任职财务主管超十余年。GEMS是一家私募股权管理公司,投资于中国和亚洲地区,并管理超过8亿美元的资金。在此期间,蔡先生也负责管理Simon Murray先生家族办公室的财务及投融资活动。在2000年加入GEMS之前,蔡先生在一家上市公司工作了6年,主要从事内部控制、公司金融和资产管理工作。

    蔡先生拥有工商管理学士学位、会计硕士文凭以及基督教研究硕士学位。

CONTACT
ADDRESS
Principal Place of Business
Suite 3406 Jardine House, 1 Connaught Place, Central, Hong Kong
Telephone & Fax
Tel: +852 2360 2798
Fax: +852 2360 2799
Email
Kevin Yip: kyip@gre-inv.com
Kester Ng: kng@gre-inv.com
© GRE INVESTMENT ADVISORS LIMITED. All rights reserved.
联系我们
公司地址
香港中环康乐广场1号怡和大厦3406室
电话和传真
电话: +852 2360 2798
传真: +852 2360 2799
电子邮件
叶家祺: kyip@gre-inv.com
吴绳祖: kng@gre-inv.com
© GRE INVESTMENT ADVISORS LIMITED. All rights reserved.
EN / 中文